Update on Migraine and Parkinson Disease: 3 New Studies

New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.

Related Videos
Related Content

This Week on NeurologyLive® — March 20, 2023

March 20th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Physical Frailty Shows Association With Incident Parkinson Disease, Modified by Genetic Risk

March 16th 2023

NeuroVoices: Justin Sporrer, MD, on Improvements and Benefits to High Intensity Focused Ultrasound in Essential Tremor

March 15th 2023

This Week on NeurologyLive® — March 20, 2023

March 20th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Physical Frailty Shows Association With Incident Parkinson Disease, Modified by Genetic Risk

March 16th 2023

NeuroVoices: Justin Sporrer, MD, on Improvements and Benefits to High Intensity Focused Ultrasound in Essential Tremor

March 15th 2023

This Week on NeurologyLive® — March 20, 2023

March 20th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Physical Frailty Shows Association With Incident Parkinson Disease, Modified by Genetic Risk

March 16th 2023

NeuroVoices: Justin Sporrer, MD, on Improvements and Benefits to High Intensity Focused Ultrasound in Essential Tremor

March 15th 2023
© 2023 MJH Life Sciences

All rights reserved.